Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Multicenter, Open-label, Dose-Exploration and Dose-Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 650 in Subjects With Advanced Solid Tumors

NCT04293094 is registered in ClinicalTrials.gov with Volastra Therapeutics, Inc. as lead sponsor.

NCT NCT04293094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04293094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Multicenter, Open-label, Dose-Exploration and Dose-Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 650 in Subjects With Advanced Solid Tumors
Lead sponsor
Volastra Therapeutics, Inc.
Phase
Phase 1
Overall status
Completed
Start date
March 11, 2020
Completion date
February 15, 2023
Enrollment
66 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors